136 related articles for article (PubMed ID: 25865000)
1. Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin.
Darabi F; Marzo T; Massai L; Scaletti F; Michelucci E; Messori L
J Inorg Biochem; 2015 Aug; 149():102-7. PubMed ID: 25865000
[TBL] [Abstract][Full Text] [Related]
2. Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins.
Marzo T; Navas F; Cirri D; Merlino A; Ferraro G; Messori L; Quiroga AG
J Inorg Biochem; 2018 Apr; 181():11-17. PubMed ID: 29353085
[TBL] [Abstract][Full Text] [Related]
3. The mode of action of anticancer gold-based drugs: a structural perspective.
Messori L; Scaletti F; Massai L; Cinellu MA; Gabbiani C; Vergara A; Merlino A
Chem Commun (Camb); 2013 Oct; 49(86):10100-2. PubMed ID: 24045294
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of aurothiomalate-Cys2His2 zinc finger interactions.
Larabee JL; Hocker JR; Hanas JS
Chem Res Toxicol; 2005 Dec; 18(12):1943-54. PubMed ID: 16359185
[TBL] [Abstract][Full Text] [Related]
5. Partial cross-resistance between auranofin and sodium aurothiomalate in cultured human cells.
Rugstad HE; Glennås A
Scand J Rheumatol; 1988; 17(3):175-81. PubMed ID: 3140371
[TBL] [Abstract][Full Text] [Related]
6. Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme.
Gabbiani C; Massai L; Scaletti F; Michelucci E; Maiore L; Cinellu MA; Messori L
J Biol Inorg Chem; 2012 Dec; 17(8):1293-302. PubMed ID: 23132507
[TBL] [Abstract][Full Text] [Related]
7. Reactions with Proteins of Three Novel Anticancer Platinum(II) Complexes Bearing N-Heterocyclic Ligands.
Sacco F; Tarchi M; Ferraro G; Merlino A; Facchetti G; Rimoldi I; Messori L; Massai L
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638887
[TBL] [Abstract][Full Text] [Related]
8. Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound.
Messori L; Scaletti F; Massai L; Cinellu MA; Russo Krauss I; di Martino G; Vergara A; Paduano L; Merlino A
Metallomics; 2014 Feb; 6(2):233-6. PubMed ID: 24287583
[TBL] [Abstract][Full Text] [Related]
9. Effects of antirheumatic gold compounds on the conversion of xanthine dehydrogenase to oxidase in rabbit liver cytosol in vitro.
Sakuma S; Gotoh K; Sadatoku N; Fujita T; Fujimoto Y
Life Sci; 2004 Jul; 75(10):1211-8. PubMed ID: 15219809
[TBL] [Abstract][Full Text] [Related]
10. In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance.
Iqbal MS; Taqi SG; Arif M; Wasim M; Sher M
Biol Trace Elem Res; 2009 Sep; 130(3):204-9. PubMed ID: 19194667
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of production of macrophage-derived angiogenic activity by the anti-rheumatic agents gold sodium thiomalate and auranofin.
Koch AE; Cho M; Burrows J; Leibovich SJ; Polverini PJ
Biochem Biophys Res Commun; 1988 Jul; 154(1):205-12. PubMed ID: 2456062
[TBL] [Abstract][Full Text] [Related]
12. Effects of gold(I) antiarthritic drugs and related compounds on Pseudomonas putida.
Rhodes MD; Sadler PJ; Scawen MD; Silver S
J Inorg Biochem; 1992 May; 46(2):129-42. PubMed ID: 1355789
[TBL] [Abstract][Full Text] [Related]
13. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
14. Gold(I) ion and the phosphine ligand are necessary for the anti-
Ma CI; Tirtorahardjo JA; Schweizer SS; Zhang J; Fang Z; Xing L; Xu M; Herman DA; Kleinman MT; McCullough BS; Barrios AM; Andrade RM
Microbiol Spectr; 2024 Feb; 12(2):e0296823. PubMed ID: 38206030
[TBL] [Abstract][Full Text] [Related]
15. [Effects of gold compounds on lymphocyte transformation and neutrophil chemotaxis--a comparison between sodium aurothiomalate and auranofin].
Negishi M; Sato H; Sekine F; Ohno I; Kobayashi K; Ohseto Y; Hamai T; Takahashi T
Ryumachi; 1983 Jun; 23(3):163-7. PubMed ID: 6414094
[No Abstract] [Full Text] [Related]
16. Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions.
Handel ML; deFazio A; Watts CK; Day RO; Sutherland RL
Mol Pharmacol; 1991 Nov; 40(5):613-8. PubMed ID: 1944234
[TBL] [Abstract][Full Text] [Related]
17. Ploidity and cell cycle progression during treatment with gold chloride, auranofin and sodium aurothiomalate. Studies on a human epithelial cell line and its sub-strains made resistant to the antiproliferative effects of these gold compounds.
Glennås A; Rugstad HE
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(4):385-93. PubMed ID: 2867637
[TBL] [Abstract][Full Text] [Related]
18. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on lymphocyte subsets of patients with rheumatoid arthritis.
Pedersen BK; Abom B
Allergy; 1988 Jul; 43(5):396-8. PubMed ID: 2970811
[TBL] [Abstract][Full Text] [Related]
19. Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.
Hill DT; Isab AA; Griswold DE; DiMartino MJ; Matz ED; Figueroa AL; Wawro JE; DeBrosse C; Reiff WM; Elder RC; Jones B; Webb JW; Shaw CF
Inorg Chem; 2010 Sep; 49(17):7663-75. PubMed ID: 20704360
[TBL] [Abstract][Full Text] [Related]
20. A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin.
De Luca A; Hartinger CG; Dyson PJ; Lo Bello M; Casini A
J Inorg Biochem; 2013 Feb; 119():38-42. PubMed ID: 23183361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
